Start-Up Spotlight: Atlantic Therapeutics, Stimulating The Stress Incontinence Market With Vaginal Mesh Alternative
While controversy over vaginal mesh implants and the serious complications resulting from these devices eroding inside the patient continue unabated across the globe, one Irish company is looking to capitalize on this opportune time by offering a noninvasive solution to stress urinary incontinence. Atlantic Therapeutics has recently won the backing of European healthcare VCs, raising €15m in a Series A round.
You may also be interested in...
Atlantic Therapeutics has appointed former Zeltiq Aesthetics CEO Gordie Nye as its new chairman to help drive adoption of its CE-marked Innovo device for treating clinical conditions associated with pelvic floor weakness.
Vagisil and BioFilm’s Astroglide “demonstrate very high levels of brand awareness, brand loyalty, and repeat purchase, and continue to attract new and younger consumers into the category,” firms say.
Nicotine mint lozenge approval for Perrigo; Lightbody for digital vision health; PLT has broad-spectrum immune health ingredient; Souvenaid for stronger synapses; Kinesiology tape for cellular oxygenation; Healthycell joint health and mobility gel; Nature’s Bounty Optimal Solutions hair, metabolism supplements; and Perricone extends vitamin c ester line.